Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{5bddc42b0a2b42a6a57a85b57df84a92,
title = "A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals",
abstract = "Post-bariatric hypoglycemia (PBH) can be a serious complication after Roux-en-Y gastric bypass (RYGB), and treatment with somatostatin analogs has been suggested. We investigated the acute effects of three different doses of pasireotide (75 μg, 150 μg, and 300 μg) on the postprandial glucose metabolism in five RYGB-operated individuals with PBH using a mixed meal test. All three doses prevented hypoglycemia but were associated with a notable increase in postprandial hyperglycemia. Moreover, all doses greatly diminished insulin, C-peptide, and glucagon-like peptide-1 responses. Considering its strong hyperglycemic potential, we suggest that pasireotide should be administered carefully in RYGB-operated individuals with PBH, and if necessary, a 75 μg dose seems sufficient to prevent hypoglycemia.",
keywords = "Gastric bypass, Hyperglycemia, Hypoglycemia, Pasireotide, Somatostatin analogs",
author = "{\O}hrstr{\o}m, {Caroline C} and Hansen, {Dorte L} and Kielgast, {Urd Lynge} and Bolette Hartmann and Holst, {Jens Juul} and Dorte Worm",
year = "2019",
month = "11",
day = "10",
doi = "10.1007/s11695-019-04248-x",
language = "English",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York LLC",

}

RIS

TY - JOUR

T1 - A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals

AU - Øhrstrøm, Caroline C

AU - Hansen, Dorte L

AU - Kielgast, Urd Lynge

AU - Hartmann, Bolette

AU - Holst, Jens Juul

AU - Worm, Dorte

PY - 2019/11/10

Y1 - 2019/11/10

N2 - Post-bariatric hypoglycemia (PBH) can be a serious complication after Roux-en-Y gastric bypass (RYGB), and treatment with somatostatin analogs has been suggested. We investigated the acute effects of three different doses of pasireotide (75 μg, 150 μg, and 300 μg) on the postprandial glucose metabolism in five RYGB-operated individuals with PBH using a mixed meal test. All three doses prevented hypoglycemia but were associated with a notable increase in postprandial hyperglycemia. Moreover, all doses greatly diminished insulin, C-peptide, and glucagon-like peptide-1 responses. Considering its strong hyperglycemic potential, we suggest that pasireotide should be administered carefully in RYGB-operated individuals with PBH, and if necessary, a 75 μg dose seems sufficient to prevent hypoglycemia.

AB - Post-bariatric hypoglycemia (PBH) can be a serious complication after Roux-en-Y gastric bypass (RYGB), and treatment with somatostatin analogs has been suggested. We investigated the acute effects of three different doses of pasireotide (75 μg, 150 μg, and 300 μg) on the postprandial glucose metabolism in five RYGB-operated individuals with PBH using a mixed meal test. All three doses prevented hypoglycemia but were associated with a notable increase in postprandial hyperglycemia. Moreover, all doses greatly diminished insulin, C-peptide, and glucagon-like peptide-1 responses. Considering its strong hyperglycemic potential, we suggest that pasireotide should be administered carefully in RYGB-operated individuals with PBH, and if necessary, a 75 μg dose seems sufficient to prevent hypoglycemia.

KW - Gastric bypass

KW - Hyperglycemia

KW - Hypoglycemia

KW - Pasireotide

KW - Somatostatin analogs

UR - http://www.scopus.com/inward/record.url?scp=85074862039&partnerID=8YFLogxK

U2 - 10.1007/s11695-019-04248-x

DO - 10.1007/s11695-019-04248-x

M3 - Journal article

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

ER -

ID: 58351450